Tags

Type your tag names separated by a space and hit enter

Impetigo herpetiformis in a primigravida: successful treatment with etretinate.
J Drugs Dermatol. 2004 Jul-Aug; 3(4):449-51.JD

Abstract

Impetigo herpetiformis (IH) is a rare dermatosis which usually occurs during the third trimester of pregnancy. It is characterized by acute erythematosquamous plaques covered with tiny superficial pustules in a herpetiform distribution with less likely mucus membranes involvement. It can be associated with constitutional symptom s such as fever, chills, nausea, vomiting and diarrhea. Impetigo herpetiformis can cause serious complications to the mother and fetus which include: maternal hypocalcemia leading to delirium, convulsions, and tetany in the mother, and placental insufficiency leading to still birth, neonatal death or fetal abnormalities. Lesions are expected to disappear after birth but may recur during subsequent pregnancies at an earlier gestational age. Presented here is a case of IH occurring during the 37th week of gestation in a primigravida who failed to respond to oral steroid but successfully cleared with oral etretinate.

Authors+Show Affiliations

Department of Dermatology, King Faisal University, College of Medicine and Medical Sciences. consultant@dermatologyclinics.net

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

15303793

Citation

Bukhari, Iqbal A.. "Impetigo Herpetiformis in a Primigravida: Successful Treatment With Etretinate." Journal of Drugs in Dermatology : JDD, vol. 3, no. 4, 2004, pp. 449-51.
Bukhari IA. Impetigo herpetiformis in a primigravida: successful treatment with etretinate. J Drugs Dermatol. 2004;3(4):449-51.
Bukhari, I. A. (2004). Impetigo herpetiformis in a primigravida: successful treatment with etretinate. Journal of Drugs in Dermatology : JDD, 3(4), 449-51.
Bukhari IA. Impetigo Herpetiformis in a Primigravida: Successful Treatment With Etretinate. J Drugs Dermatol. 2004 Jul-Aug;3(4):449-51. PubMed PMID: 15303793.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Impetigo herpetiformis in a primigravida: successful treatment with etretinate. A1 - Bukhari,Iqbal A, PY - 2004/8/12/pubmed PY - 2004/12/16/medline PY - 2004/8/12/entrez SP - 449 EP - 51 JF - Journal of drugs in dermatology : JDD JO - J Drugs Dermatol VL - 3 IS - 4 N2 - Impetigo herpetiformis (IH) is a rare dermatosis which usually occurs during the third trimester of pregnancy. It is characterized by acute erythematosquamous plaques covered with tiny superficial pustules in a herpetiform distribution with less likely mucus membranes involvement. It can be associated with constitutional symptom s such as fever, chills, nausea, vomiting and diarrhea. Impetigo herpetiformis can cause serious complications to the mother and fetus which include: maternal hypocalcemia leading to delirium, convulsions, and tetany in the mother, and placental insufficiency leading to still birth, neonatal death or fetal abnormalities. Lesions are expected to disappear after birth but may recur during subsequent pregnancies at an earlier gestational age. Presented here is a case of IH occurring during the 37th week of gestation in a primigravida who failed to respond to oral steroid but successfully cleared with oral etretinate. SN - 1545-9616 UR - https://www.unboundmedicine.com/medline/citation/15303793/Impetigo_herpetiformis_in_a_primigravida:_successful_treatment_with_etretinate_ DB - PRIME DP - Unbound Medicine ER -